Pharmaceutical Manufacturing Handbook: Production and

642 NASAL DELIVERY OF PEPTIDE AND NONPEPTIDE DRUGS
80. Miron , T. , and Wilcheck , M. ( 1993 ), A simplifi ed method for the preparation of succinimidyl
carbonate polyethylene glycol for coupling to proteins , Biconj. Chem. , 4 ,
568 – 569 .
81. Shin , B. S. , Jung , J. H. , Lee , K. C. , and Yoo , S. D. ( 2004 ), Nasal absorption and pharmacokinetic
disposition of salmon calcitonin modifi ed with low molecular weight polyethylene
glycol , Chem. Pharm. Bull. , 52 , 957 – 960 .
82. Na , D. H. , Youn , Y. S. , Park , E. J. , Lee , J. M. , Cho , O. R. , Lee , K. R. , Lee , S. D. , Yoo , S. D. ,
Deluca , P. P. , and Lee , K. C. ( 2004 ), Stability of PEGylated salmon calcitonin in nasal
mucosa , J. Pharm. Sci. , 93 , 256 – 261 .
83. Arnold , J. J. , Ahsan , F. , Meezan , E. , and Pillion , D. J. ( 2002 ), Nasal administration of low
molecular weight heparin , J. Pharm. Sci. , 91 , 1707 – 1714 .
84. Yang , T. , Mustafa , F. , and Ahsan , F. ( 2004 ), Alkanoylsucroses in nasal delivery of low
molecular weight heparins: In - vivo absorption and reversibility studies in rats , J. Pharm.
Pharmacol. , 56 , 53 – 60 .
85. Mustafa , F. , Yang , T. , Khan , M. A. , and Ahsan , F. ( 2004 ), Chain length - dependent effects
of alkylmaltosides on nasal absorption of enoxaparin , J. Pharm. Sci. , 93 , 675 – 683 .
86. Yang , T. , Hussain , A. , Paulson , J. , Abbruscato , T. J. , and Ahsan , F. ( 2004 ), Cyclodextrins
in nasal delivery of low - molecular - weight heparins: In vivo and in vitro studies , Pharm.
Res. , 21 , 1127 – 1136 .
87. Yang , T. , Hussain , A. , Bai , S. , Khalil , I. A. , Harashima , H. , and Ahsan , F. ( 2006 ), Positively
charged polyethylenimines enhance nasal absorption of the negatively charged drug,
low molecular weight heparin , J. Controlled Release , 115 , 289 – 297 .
88. Mason , G. A. , Garbutt , J. C. , and Prange Jr ., A. J. ( 2000 ), Thyrotropin releasing
hormone: Focus On neurobiology, available: http://www.acnp.org/g4/GN401000048/
CH048.html .
89. Yamamoto , M. , and Shimizu , M. ( 1987 ), Effects of new TRH analogue, YM - 14673 on
the central nervous system , Naunyn. Schmiedebergs. Arch. Pharmacol. , 336 , 561 – 565 .
90. Kagatani , S. , Inaba , N. , Fukui , M. , and Sonobe , T. ( 1998 ), Nasal absorption kinetic behavior
of Azetirelin and its enhancement by acylcarnitines in rats , Pharm. Res. , 15 , 77 – 81 .
91. Mitsuma , T. , and Nogimori , T. ( 1984 ), Changes in plasma thyrotrophin - releasing hormone,
thyrotrophin, prolactin and thyroid hormone levels after intravenous, intranasal or rectal
administration of synthetic thyrotrophin - releasing hormone in man , Acta Endocrinol. ,
107 , 207 – 212 .
92. Laursen , T. , Grandjean , T. , Jorgensen , J. O. , and Christiansen , J. S. ( 1996 ), Bioavailability
and bioactivity of three different doses of nasal growth hormone (GH) administered to
GH - defi cient patients: Comparison with intravenous and subcutaneous administration ,
Eur. J. Endocrinol. , 135 , 309 – 315 .
93. Leitner , V. M. , Guggi , D. , Krauland A. H. , and Bernkop - Schnurch , A. ( 2004 ), Nasal
delivery of human growth hormone: In vitro and in vivo evaluation of a thiomer/glutathione
microparticulate delivery system , J. Controlled. Release , 100 , 87 – 95 .
94. Hedin , L. , Olsson , B. , Diczfalusy , M. , Flyg , C. , Petersson , A. S. , Rosberg , S. , and Albertsson
- Wikland , K. ( 1993 ), Intranasal administration of human growth hormone (hGH) in
combination with a membrane permeation enhancer in patients with GH defi ciency: A
pharmacokinetic study , J. Clin. Endocrinol. Metab. , 76 , 962 – 967 .
95. Albertsson - Wikland , K. , and Rosberg , S. ( 1988 ), Analyses of 24 - hour growth hormone
(GH) profi les in children , J. Clin. Endocrinol. Metab. , 67 , 493 – 500 .
96. Clark , R. G. , Jansson , J. O. , Isaksson , O. , and Robinson , I. C. A. F. ( 1985 ), Intravenous
growth hormone: Growth responses to patterned infusions in hypophysectomized rats ,
J. Endocrinol. , 104 , 53 – 61 .